Researchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.

Genome editing advances drug discovery in biomedical research.

Accomplished female scientists at Novartis share their wisdom born from difficult moments in life.

Researchers improve our understanding about how compounds bind to proteins in the cell membrane—and the membrane itself.

Alexandra Bach-Weidmuller, Head of Program and Project Management at NIBR, describes her path to leadership as lateral instead of upward.

Physician-scientist Cyndy Grosskreutz explains why she transitioned from academia to industry.

Cardiovascular researcher Jennifer Allport-Anderson describes the personal qualities and decisions that have made her a successful leader.